Nurse Practitioner, Family · Idaho Falls, ID
NPI
1336895861
Since 2022
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
3245 Channing Way
Idaho Falls, ID, 83404
Phone (208) 227-2700
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$648K
205 prescriptions
Company payments, 2025
$3,715
From 41 companies
Medicare prescription drug claims, 2024
In 2024, the drug Sunita Sigdel prescribed most often to Medicare patients was Gabapentin, with 47 prescriptions and refills. In total Sunita Sigdel wrote 205 Medicare prescriptions that cost $648K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-23.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Gabapentin Generic | 47 | 76 | 15 | $270 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 24 | 24 | Under 11 | $555 |
| Oxycodone Hcl Generic | 15 | 15 | Under 11 | $177 |
| Gilotrif Afatinib Dimaleate | 13 | 13 | Under 11 | $306K |
Brand drugs: 32 claims; generic drugs: 173 claims; opioid claims: 58.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sunita Sigdel $3,715 ($3,715 in general payments such as food, travel and fees) from 41 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $474.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 11 | $474 |
| Janssen Biotech, Inc. JNJ | 11 | $342 |
| Daiichi Sankyo Inc. 4568.T | 10 | $223 |
| Abbvie Inc. ABBV | 6 | $217 |
| Pfizer Inc. PFE | 19 | $196 |
| Merck Sharp & Dohme LLC MRK | 7 | $172 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $157 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $145 |
| Aveo Pharmaceuticals, Inc. | 8 | $141 |
| Exelixis Inc. EXEL | 3 | $136 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.